SDUY816 is an oral active dual APN/NEP inhibitor, with IC50 values of 0.68 µM for APN and 6.9 µM for NEP. SDUY816 exhibits analgesic effects and demonstrates good safety and pharmacokinetic profiles, with an oral bioavailability of 27% and a half-life of 4.02 hours in rats (oral administration, 10 mg/kg). SDUY816 has potential applications in the research of neuropathic pain disorders[1].
Molekulargewicht:
449.24
Formel:
C18H16IN3O3
Target-Kategorie:
Aminopeptidase,Neprilysin
Anwendungsbeschreibung:
MCE Product type: Reference compound1
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
